ATF-7IP Activators
ATF7IP activators are a class of chemicals that can potentially influence the activity of the ATF7IP protein. These compounds primarily act by interfering with chromatin remodeling processes, which can indirectly affect the function of ATF7IP.
Members of this class include trichostatin A, sodium butyrate, valproic acid, romidepsin, vorinostat, entinostat, panobinostat, belinostat, givinostat, tacedinaline, pracinostat, and chidamide. These are all inhibitors of histone deacetylases. By inhibiting these enzymes, they increase the acetylation of histones, leading to a more open and relaxed chromatin structure. This can potentially lead to the de-repression of MBD1 target genes, which are regulated by ATF7IP. In this way, these chemicals can indirectly affect the gene silencing activity of ATF7IP by modifying the chromatin conformation.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Trichostatin A | 58880-19-6 | sc-3511 sc-3511A sc-3511B sc-3511C sc-3511D | 1 mg 5 mg 10 mg 25 mg 50 mg | $152.00 $479.00 $632.00 $1223.00 $2132.00 | 33 | |
Trichostatin A is an inhibitor of histone deacetylases, which can increase the acetylation of histones, thereby loosening the chromatin structure and potentially leading to the de-repression of MBD1 target genes modulated by ATF7IP. | ||||||
Sodium Butyrate | 156-54-7 | sc-202341 sc-202341B sc-202341A sc-202341C | 250 mg 5 g 25 g 500 g | $31.00 $47.00 $84.00 $222.00 | 19 | |
Sodium butyrate is another histone deacetylase inhibitor. By increasing histone acetylation, it can potentially modify the chromatin structure and influence the gene silencing activity of ATF7IP. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $87.00 | 9 | |
Valproic acid is a histone deacetylase inhibitor that can alter chromatin conformation and may indirectly influence ATF7IP activity. | ||||||
Romidepsin | 128517-07-7 | sc-364603 sc-364603A | 1 mg 5 mg | $218.00 $634.00 | 1 | |
Romidepsin is a histone deacetylase inhibitor. By modifying the chromatin conformation, it may indirectly influence ATF7IP activity. | ||||||
Suberoylanilide Hydroxamic Acid | 149647-78-9 | sc-220139 sc-220139A | 100 mg 500 mg | $133.00 $275.00 | 37 | |
Vorinostat, another histone deacetylase inhibitor, can alter chromatin structure and may indirectly influence ATF7IP activity. | ||||||
MS-275 | 209783-80-2 | sc-279455 sc-279455A sc-279455B | 1 mg 5 mg 25 mg | $24.00 $90.00 $212.00 | 24 | |
MS-275 is a histone deacetylase inhibitor that can modify chromatin conformation and may indirectly influence ATF7IP activity. | ||||||
Panobinostat | 404950-80-7 | sc-208148 | 10 mg | $200.00 | 9 | |
Panobinostat is a histone deacetylase inhibitor that can alter chromatin conformation and may indirectly influence ATF7IP activity. | ||||||
Belinostat | 414864-00-9 | sc-269851 sc-269851A | 10 mg 100 mg | $156.00 $572.00 | ||
Belinostat, a histone deacetylase inhibitor, can modify chromatin conformation and may indirectly influence ATF7IP activity. | ||||||
ITF2357 | 732302-99-7 | sc-364513 sc-364513A | 5 mg 50 mg | $340.00 $1950.00 | ||
ITF2357 is a histone deacetylase inhibitor that can modify chromatin conformation and may indirectly influence ATF7IP activity. | ||||||
CI 994 | 112522-64-2 | sc-205245 sc-205245A | 10 mg 50 mg | $99.00 $536.00 | 1 | |
CI 994 is a histone deacetylase inhibitor that can alter chromatin conformation and may indirectly influence ATF7IP activity. | ||||||